M&A

Pfizer’s Hospira Deal: Catching Up a Year Later
Market Realist
Mon, 09/12/16 - 09:45 am
Pfizer
Hospira
M&A
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Motley Fool
Mon, 09/12/16 - 09:34 am
Gilead Sciences
M&A
JNJ
Novartis
Amgen
Pfizer
Merck
Evaluating a GW Pharma Merger, Maybe
Yahoo/24-7
Sun, 09/11/16 - 10:11 pm
GW Pharma
M&A
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Bayer eyes $1B-plus dermatology sale to fund Monsanto quest
Fierce Pharma
Fri, 09/9/16 - 11:37 am
Bayer
dermatology
Monsanto
M&A
M&A Means Big Shifts in Medtech Job Numbers
Qmed
Fri, 09/9/16 - 10:20 am
M&A
devices
jobs
St. Jude
Zimmer Biomet
BD Medical
Debt-laden Valeant can't afford to say 'never' to selling off Bausch & Lomb, CEO says
Fierce Pharma
Thu, 09/8/16 - 06:35 pm
Valeant Pharmaceuticals
M&A
Bausch & Lomb
Abbott, Alere agree to mediate merger dispute
Yahoo/Reuters
Thu, 09/8/16 - 06:30 pm
Abbott Labs
Alere
M&A
devices
Analyzing Sanofi’s Asset Swap Deal with Boehringer Ingelheim
Market Realist
Thu, 09/8/16 - 06:29 pm
Sanofi
Boehringer Ingelheim
animal health
M&A
Merial
consumer health
GW Pharma spikes as the latest buyout rumors swirl around cannabinoid pipeline
Endpoints
Wed, 09/7/16 - 08:24 pm
GW Pharma
cannabis
M&A
3 Hottest Cancer Biotech Acquisition Targets After Medivation
Forbes
Tue, 09/6/16 - 11:11 pm
cancer
biotech
M&A
Puma Biotechnology
Jazz Pharmaceuticals
Kite Pharma
Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Endpoints
Tue, 09/6/16 - 09:53 am
Allergan
gene therapy
RetroSense Therapeutics
M&A
Navidea stock jumps 76% after agreeing to $80 million Cardinal Health deal
Marketwatch
Tue, 09/6/16 - 09:52 am
Navidea Biopharmaceuticals
Cardinal Health
Lymphoseek
M&A
Is Biogen a Worthwhile Buyout Candidate?
Motley Fool
Mon, 09/5/16 - 10:06 am
Biogen
M&A
Allergan
Merck
Nestlé’s health science unit inks staged acquisition of Phagesis
Mass Device
Mon, 09/5/16 - 10:04 am
Nestle
Phagesis
M&A
dysphagia
devices
Judge fast-tracks Alere suit against Abbott, urges mediation
Mass Device
Fri, 09/2/16 - 10:25 pm
Abbott Labs
Alere
M&A
How did Pfizer swat off rival Medivation bidders? Price, yes, but a CEO confab helped
Fierce Pharma
Fri, 09/2/16 - 11:23 am
Pfizer
Medivation
M&A
Pharma CEOs
Abbott/Alere Entanglement - Publicity Stunt Or Buyer's Remorse Or A Class Act?
Seeking Alpha
Fri, 09/2/16 - 09:37 am
Abbott Labs
Alere
M&A
diagnostics
$354M exit package in hand, Medivation CEO David Hung completes a master class in biotech auctions
Endpoints
Wed, 08/31/16 - 09:09 pm
Medivation
Pfizer
David Hung
M&A
executive pay
Abbott’s Deal for Alere Turns Nasty as Firms Brawl in Court
Bloomberg
Wed, 08/31/16 - 08:50 pm
Abbott Labs
Alere
M&A

Pages